Sort
21,281 grants matching “influenza”
Regulation of IL10 production in CD8+ T cells during Flu infection by tyrosine kinase Itk
$388,829Avery August · Cornell University · R01 · FY2018 · AI
Human T cell-mediated immunity to viruses in tissues and circulation
$388,769Donna L Farber · Columbia University Health Sciences · U19 · FY2023 · AI
Inhibition of PAR2 as therapeutic approach to enhance anti-viral immune responses
$388,750Silvio Antoniak · Univ Of North Carolina Chapel Hill · R01 · FY2019 · HL
Role of the Thrombin PAR-1 Pathway in Viral Infection
$388,750Nigel Mackman · Univ Of North Carolina Chapel Hill · R01 · FY2017 · HL
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome
$388,750Michael E. Yeager · University Of Colorado Denver · R01 · FY2021 · AI
Inhibition of PAR2 as therapeutic approach to enhance anti-viral immune responses
$388,750Silvio Antoniak · Univ Of North Carolina Chapel Hill · R01 · FY2022 · HL
Regulation and function of EC-SOD
$388,750Rodney J Folz · Duke University · R01 · FY2006 · HL
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome
$388,750Michael E. Yeager · University Of Colorado Denver · R01 · FY2023 · AI
Post Viral Bacterial Pneumonia: Role of MicroRNA and Autophagy
$388,750Urvashi Bhan · University Of Michigan At Ann Arbor · R01 · FY2014 · HL
Inhibition of PAR2 as therapeutic approach to enhance anti-viral immune responses
$388,750Silvio Antoniak · Univ Of North Carolina Chapel Hill · R01 · FY2020 · HL
Genetic and biophysical mechanisms that control influenza virus cellular multiplicity of infection
$388,750Michael D Vahey · Washington University · R01 · FY2024 · AI
Inhibition of PAR2 as therapeutic approach to enhance anti-viral immune responses
$388,750Silvio Antoniak · Univ Of North Carolina Chapel Hill · R01 · FY2018 · HL
Inhibition of PAR2 as therapeutic approach to enhance anti-viral immune responses
$388,750Silvio Antoniak · Univ Of North Carolina Chapel Hill · R01 · FY2021 · HL
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome
$388,750Michael E. Yeager · University Of Colorado Denver · R01 · FY2022 · AI
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome
$388,750Michael E. Yeager · University Of Colorado Denver · R01 · FY2020 · AI
Role of the Thrombin PAR-1 Pathway in Viral Infection
$388,750Nigel Mackman · Univ Of North Carolina Chapel Hill · R01 · FY2018 · HL
Role of the Thrombin PAR-1 Pathway in Viral Infection
$388,750Nigel Mackman · Univ Of North Carolina Chapel Hill · R01 · FY2019 · HL
Role of the Thrombin PAR-1 Pathway in Viral Infection
$388,750Nigel Mackman · Univ Of North Carolina Chapel Hill · R01 · FY2020 · HL
Persistent Post-Viral State of Bacterial Pneumonia Susceptibility and Severity in Down Syndrome
$388,750Michael E. Yeager · University Of Colorado Denver · R01 · FY2019 · AI
Molecular Mechanisms of Rhabdovirus Entry
$388,699Sean P. J. Whelan · Harvard Medical School · R01 · FY2013 · AI
The effect of human pre-exposure history on antigenic drift of influenza viruses
$388,691Scott Eric Hensley · University Of Pennsylvania · R01 · FY2017 · AI
Fidelity, robustness, and diversity in RNA virus evolution and pathogenesis
$388,675Adam Lauring · University Of Michigan At Ann Arbor · R01 · FY2020 · AI
Influenza Virus Assembly
$388,672Yoshihiro Kawaoka · University Of Wisconsin-Madison · R01 · FY2007 · AI
Enhancing Adolescent Immunization through Parent and Teacher Interventions
$388,646James M. Hughes · Emory University · U01 · FY2013 · IP
Enhancing Adolescent Immunization through Parent and Teacher Interventions
$388,646James M. Hughes · Emory University · U01 · FY2012 · IP